Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Pushes FDA To Expedite Sunscreen Ingredient Reviews

This article was originally published in The Tan Sheet

Executive Summary

Reps. Dingell and Whitfield ask for FDA’s assistance on legislation they are writing to expedite the agency’s review of additional sunscreen ingredients. CDER Director Woodcock pledges FDA help, but explains the agency’s OTC ingredient reviews are “backlogged.”

Advertisement

Related Content

Sunscreen Ingredient Legislation Could Ride Wave Of Momentum
Sunscreen Ingredient Legislation Could Ride Wave Of Momentum
FDA Sunscreen Decision Deadlines, Expedited TEAs Proposed
FDA Sunscreen Decision Deadlines, Expedited TEAs Proposed
FDA Rejects Sunscreen TEAs, Plans Public Hearing On Ingredient Review
FDA Rejects Sunscreen TEAs, Plans Public Hearing On Ingredient Review
CHPA Agenda 2014: Monograph Reform, NSURE Progress
CHPA Agenda 2014: Monograph Reform, NSURE Progress
FDA Strengthens Sunscreen Testing And Label Requirements

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106722

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel